10-K Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001564590-15-011489`
Period End Date	20150930
Filing Date	20151214
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	arwr-20150930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 85 Income Statement 115 Cash Flow Statement 118 Stockholders Equity 38

Balance Sheet 85 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	15,652.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	18,300.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.29M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	18,300.00	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$588.63K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	15,652.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$48.50K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$823.62K	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$17.54M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$21.65M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$154.80M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	54.66M	shares	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$102.87M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	59.54M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.53M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	54.66M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	59.54M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.87M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$24.82M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$3.24M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.01M	USD	Point-in-time
Investments	`HeldToMaturitySecuritiesNoncurrent`	$23.09M	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$45.79K	USD	Point-in-time
Other assets	`OtherAssetsMiscellaneousNoncurrent`	$41.41K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$132.27M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$182.82M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.03M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.58M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.40M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.38M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.82M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$3.27M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$103.12K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$103.12K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$4.17M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$1.30M	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$217.55K	USD	Point-in-time
Capital lease obligation	`CapitalLeaseObligationsCurrent`	$213.99K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$50.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$58.49K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$46.41K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$11.85M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$15.90M	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$758.34K	USD	Point-in-time
Capital lease obligation, net of current portion	`CapitalLeaseObligationsNoncurrent`	$540.79K	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$5.86M	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$1.60M	USD	Point-in-time
Contingent consideration obligations	`BusinessCombinationContingentConsiderationLiability`	$3.97M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$342.45K	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$255.21K	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$4.98M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$6.75M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 15,652 and 18,300 shares issued and outstanding as of September 30, 2015 and September 30, 2014, respectively	`PreferredStockValue`	$18.00	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 15,652 and 18,300 shares issued and outstanding as of September 30, 2015 and September 30, 2014, respectively	`PreferredStockValue`	$16.00	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 59,544,677 and 54,656,936 shares issued and outstanding as of September 30, 2015 and September 30, 2014, respectively	`CommonStockValue`	$151.91K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 59,544,677 and 54,656,936 shares issued and outstanding as of September 30, 2015 and September 30, 2014, respectively	`CommonStockValue`	$147.03K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$391.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$426.87M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-136.43K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-316.71M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-224.77M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$110.18M	USD	Point-in-time
Total Arrowhead Research Corporation stockholders' equity	`StockholdersEquity`	$166.54M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.81M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.62M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$182.82M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$132.27M	USD	Point-in-time

Income Statement 115 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`Revenues`	$290.27K	USD	Annual
REVENUE	`Revenues`	$382.00K	USD	Annual
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$170.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
REVENUE	`Revenues`	$123.75K	USD	1 Quarter
REVENUE	`Revenues`	$175.00K	USD	Annual
REVENUE	`Revenues`	$43.75K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$23.14M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$8.71M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$47.27M	USD	Annual
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.14M	USD	Annual
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$6.67M	USD	Annual
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$16.55M	USD	Annual
Salaries and payroll-related costs	`LaborAndRelatedExpense`	$12.83M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$3.49M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$5.89M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$7.93M	USD	Annual
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$10.23M	USD	Annual
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$1.54M	USD	Annual
Stock-based compensation	`AllocatedShareBasedCompensationExpense`	$5.70M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$2.34M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.35M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.75M	USD	Annual
Impairment expense	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$2.17M	USD	Annual
Impairment expense	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.31M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.89M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$2.38M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.42M	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$96.36M	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$24.88M	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$53.45M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-29.63M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-22.35M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-95.97M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-7.01M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-53.28M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-11.21M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-12.70M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-24.59M	USD	Annual
OPERATING LOSS	`OperatingIncomeLoss`	$-15.99M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-25.12M	USD	1 Quarter
OPERATING LOSS	`OperatingIncomeLoss`	$-25.23M	USD	1 Quarter
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-641.14K	USD	Annual
Equity in income (loss) of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$-78.87K	USD	Annual
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-58.88K	USD	Annual
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$19.20K	USD	Annual
Gain (loss) on sale of fixed assets, net	`GainLossOnSaleOfPropertyPlantEquipment`	$-76.39K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$729.16K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$645.49K	USD	Annual
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$-97.91K	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-6.03M	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.87M	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-5.30M	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$417.87K	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-997.98K	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$82.09K	USD	Annual
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-5.44M	USD	Annual
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$-7.11M	USD	Annual
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$4.04M	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-31.70M	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-91.94M	USD	Annual
LOSS BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-58.72M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$5.30K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.40K	USD	Annual
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-58.73M	USD	Annual
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-31.70M	USD	Annual
LOSS FROM CONTINUING OPERATIONS	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-91.94M	USD	Annual
Loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-354.00	USD	Annual
NET LOSS FROM DISCONTINUED OPERATIONS	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-354.00	USD	Annual
NET LOSS	`ProfitLoss`	$-31.70M	USD	Annual
NET LOSS	`ProfitLoss`	$-24.75M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-15.94M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-10.69M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-11.63M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-13.98M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-28.68M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-91.94M	USD	Annual
NET LOSS	`ProfitLoss`	$-22.58M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-58.73M	USD	Annual
NET LOSS	`ProfitLoss`	$-22.43M	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-560.14K	USD	Annual
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.22K	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-24.75M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-31.14M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-91.94M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-22.43M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-13.94M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-22.58M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-15.94M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-10.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-11.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-58.63M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-28.68M	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.51	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.42	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-1.25	USD	Annual
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-1.60	USD	Annual
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.28	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.42	USD	1 Quarter
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-1.30	USD	Annual
NET LOSS PER SHARE ATTRIBUTABLE TO ARROWHEAD SHAREHOLDERS - BASIC AND DILUTED:	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	46.93M	shares	Annual
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	57.36M	shares	Annual
Weighted average shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	24.00M	shares	Annual
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-136.43K	USD	Annual
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-92.08M	USD	Annual
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-58.63M	USD	Annual
COMPREHENSIVE LOSS ATTRIBUTABLE TO ARROWHEAD	`ComprehensiveIncomeNetOfTax`	$-31.14M	USD	Annual

Cash Flow Statement 118 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-31.70M	USD	Annual
Net loss	`ProfitLoss`	$-24.75M	USD	1 Quarter
Net loss	`ProfitLoss`	$-15.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-10.69M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.63M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.98M	USD	1 Quarter
Net loss	`ProfitLoss`	$-28.68M	USD	1 Quarter
Net loss	`ProfitLoss`	$-91.94M	USD	Annual
Net loss	`ProfitLoss`	$-22.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-58.73M	USD	Annual
Net loss	`ProfitLoss`	$-22.43M	USD	1 Quarter
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-560.14K	USD	Annual
Net loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.22K	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-24.75M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-31.14M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-91.94M	USD	Annual
Common stock, shares issued	`CommonStockSharesIssued`	54.66M	shares	Point-in-time
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-22.43M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-13.94M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-22.58M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-15.94M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-10.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-11.63M	USD	1 Quarter
Common stock, shares issued	`CommonStockSharesIssued`	59.54M	shares	Point-in-time
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-58.63M	USD	Annual
NET LOSS ATTRIBUTABLE TO ARROWHEAD	`NetIncomeLoss`	$-28.68M	USD	1 Quarter
Loss from discontinued operations	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax`	$-354.00	USD	Annual
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-58.88K	USD	Annual
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$19.20K	USD	Annual
(Gain) loss on disposal of fixed assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-76.39K	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-6.03M	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$2.87M	USD	Annual
Change in value of derivatives	`UnrealizedGainLossOnDerivatives`	$-5.30M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.89M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$2.38M	USD	Annual
Contingent consideration - Fair Value Adjustments	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$1.42M	USD	Annual
Acquired in-process research and development	`AcquiredInProcessResearchAndDevelopment`	$10.14M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$10.23M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$5.70M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$1.54M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$2.34M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.35M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.75M	USD	Annual
Amortization of note premiums	`InvestmentIncomeAmortizationOfPremium`	$1.11M	USD	Annual
Amortization of note premiums	`InvestmentIncomeAmortizationOfPremium`	$793.89K	USD	Annual
Amortization of note premiums	`InvestmentIncomeAmortizationOfPremium`	$128.41K	USD	Annual
Gain on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$84.72K	USD	Annual
Noncash gain in equity investment	`NonCashGainInEquityInvestment`	$87.20K	USD	Annual
Noncash impairment expense	`NonCashImpairmentCharges`	$2.32M	USD	Annual
Noncash impairment expense	`NonCashImpairmentCharges`	$2.17M	USD	Annual
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-560.14K	USD	Annual
Non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-95.22K	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$-75.00K	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$65.62K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$789.09K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-1.08K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$25.87K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-44.71K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$2.69M	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$15.81K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$2.49K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$13.29K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.81K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.41M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$2.50M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$321.65K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$3.48M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$4.44M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$27.92K	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$94.26K	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-40.38K	USD	Annual
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-187.91K	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-19.03M	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-35.42M	USD	Annual
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-65.71M	USD	Annual
Cash paid for acquisitions	`PaymentsToAcquireAssetsInvestingActivities`	$10.00M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.97M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$296.88K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.72M	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$500.00	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$10.00K	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$89.50K	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$10.73M	USD	Annual
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$46.37M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.42M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$11.59M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$26.09M	USD	Annual
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-9.52M	USD	Annual
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$14.12M	USD	Annual
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-36.48M	USD	Annual
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$214.80K	USD	Annual
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$213.99K	USD	Annual
Principal payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$225.41K	USD	Annual
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$172.64M	USD	Annual
Proceeds from issuance of common stock and preferred stock, net	`ProceedsFromIssuanceOrSaleOfEquity`	$42.45M	USD	Annual
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$2.06M	USD	Annual
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$504.51K	USD	Annual
Proceeds from the exercise of warrants and stock options	`ProceedsFromExerciseOfWarrantsAndStockOptions`	$12.88M	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$185.29M	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$44.29M	USD	Annual
NET CASH PROVIDED BY FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$290.52K	USD	Annual
Operating cash flows	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-354.00	USD	Annual
Net cash used in discontinued operations:	`NetCashProvidedByUsedInDiscontinuedOperations`	$-354.00	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-51.30M	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$113.40M	USD	Annual
NET INCREASE (DECREASE) IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$15.74M	USD	Annual
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
CASH AT BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$132.51M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$3.38M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$81.21M	USD	Point-in-time
CASH AT END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$19.11M	USD	Point-in-time
Interest paid	`InterestPaid`	$25.64K	USD	Annual
Interest paid	`InterestPaid`	$42.04K	USD	Annual
Interest paid	`InterestPaid`	$14.43K	USD	Annual
3,321,383 shares of Common stock issued to Novartis for asset acquisition	`CommonStockIssuedForAssetAcquisition`	$25.00M	USD	Annual

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.81M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.62M	USD	Point-in-time
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$2.05M	USD	Annual
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$401.88K	USD	Annual
Exercise of warrants, Amount	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$10.15M	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.73M	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$101.87K	USD	Annual
Stock options exercised, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.58K	USD	Annual
Stock options exercised	`StockIssuedDuringPeriodSharesStockOptionsExercised`	28,758.00	shares	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.23M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.70M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.54M	USD	Annual
Exercise of exchange rights, Amount	`ExchangeRightsExercisedDuringPeriodValue`	$3.07K	USD	Annual
Subscription payment	`SubscriptionReceivable`	$16.00K	USD	Annual
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	6.33M	shares	Point-in-time
Stock issuances, Shares	`StockIssuedDuringPeriodSharesNewIssues`	3.07M	shares	Point-in-time
Establish and settlements related to derivative liability	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$5.96M	USD	Annual
Establish and settlements related to derivative liability	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$1.60M	USD	Annual
Deconsolidation of Calando Pharmaceuticals, Inc.	`NoncontrollingInterestDecreaseFromDeconsolidation`	$1.30M	USD	Annual
Common stock-RSU vesting, Amount	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-26.03K	USD	Annual
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-136.43K	USD	Annual
Net loss	`ProfitLoss`	$-31.70M	USD	Annual
Net loss	`ProfitLoss`	$-24.75M	USD	1 Quarter
Net loss	`ProfitLoss`	$-15.94M	USD	1 Quarter
Net loss	`ProfitLoss`	$-10.69M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.63M	USD	1 Quarter
Net loss	`ProfitLoss`	$-13.98M	USD	1 Quarter
Net loss	`ProfitLoss`	$-28.68M	USD	1 Quarter
Net loss	`ProfitLoss`	$-91.94M	USD	Annual
Net loss	`ProfitLoss`	$-22.58M	USD	1 Quarter
Net loss	`ProfitLoss`	$-58.73M	USD	Annual
Net loss	`ProfitLoss`	$-22.43M	USD	1 Quarter
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$165.99M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.81M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.73M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$109.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.